Lüttecke K
J Int Med Res. 1978;6(2):86-8. doi: 10.1177/030006057800600202.
In a double-blind crossover trial of three days duration on each drug, trimebutine in a dose of 200 mg three times daily was significantly more effective than placebo in relieving the symptoms of mild to moderate degrees of spastic colon (p less than 0.001). The only side-effect necessitating discontinuation of treatment was one case of vomiting.
在一项针对每种药物为期三天的双盲交叉试验中,曲美布汀每日三次、每次200毫克的剂量在缓解轻至中度痉挛性结肠症状方面比安慰剂显著更有效(p<0.001)。唯一需要停药的副作用是1例呕吐。